Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vault RNA 3-1 pseudogene (VTRNA3-1P), previously known as hvg-4, is annotated in the human genome (located on chromosome Xp11.2), but classified as a pseudogene due to an absence of expression and the presence of silencing mutations in its promoter[2][4]. Unlike other vault RNAs, which are non-coding RNAs transcribed by RNA polymerase III and play roles in the vault ribonucleoprotein particle and in diverse cellular processes, VTRNA3-1P/hvg-4 is considered nonfunctional. It does not appear to participate in known biological functions, disease processes, or therapeutic interactions[2][4].
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vault RNA 3-1 pseudogene (VTRNA3-1P).